Prosecution Insights
Last updated: April 19, 2026

Examiner: WRIGHT, ERIC BRANDON

Tech Center 1600 • Art Units: 1632

This examiner grants 0% of resolved cases

Performance Statistics

%
Allow Rate
-60.0% vs TC avg
5
Total Applications
Interview Lift
1175
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

4.2%
§101 Eligibility
8.3%
§102 Novelty
20.8%
§103 Obviousness
54.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18605786 GENETICALLY MODIFIED MOUSE EXPRESSING HUMAN APOE4 AND MOUSE TREM2 P.R47H AND METHODS OF USE THEREOF Non-Final OA Indiana University Research and Technology Corporation
18508623 TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MYELOID DERIVED SUPPRESSOR CELLS Non-Final OA Therapeutic Solutions International, Inc.
18504883 Optimized cell culture medium utilizing iron (III) citrate as an iron delivery method for the in vitro, bioreactor-centric production of manufactured blood Non-Final OA Sciperio, Inc
18506225 PRESERVATION SOLUTION, PRESERVATION SYSTEM AND METHOD FOR PRESERVING BIOLOGICAL TISSUES IN VITRO, IN PARTICULAR CORNEAL TISSUES Non-Final OA AL.CHI.MI.A. S.R.L.
18094501 METHODS FOR TREATING ACUTE RESPIRATORY INFLAMMATORY CONDITIONS AND CYTOKINE STORM SYNDROME Non-Final OA REMEDY CELL LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month